Rob’s Path to Possible With Jakafi® (ruxolitinib) скачать в хорошем качестве

Rob’s Path to Possible With Jakafi® (ruxolitinib)

Arkansas pediatrician Rob was used to being in the provider role for most of his life, until ongoing abdominal discomfort and unexpected weight loss prompted him to see his own doctor—and he became the patient. Tests revealed high hematocrit (HCT) levels, as well as a significantly enlarged spleen. A referral to a hematologist confirmed that Rob had polycythemia vera, or PV, a rare, chronic blood cancer. After treatment with hydroxyurea (HU) failed to control his blood counts or improve his spleen size, Rob was referred to a specialist, who recommended that he begin treatment with Jakafi® (ruxolitinib). Hear Rob explain how Jakafi helped him move his PV journey forward. Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it. Selected Safety Information Jakafi can cause serious side effects including low blood counts and infection. Some people who take Jakafi have developed certain types of non‐melanoma skin cancers. Increases in blood cholesterol levels can also occur. In patients who took another JAK inhibitor to treat rheumatoid arthritis, there was an increased risk of potentially fatal cardiovascular events like heart attack or stroke in patients with risk factors for these events who smoke now or smoked in the past, as well as an increased risk of blood clots in legs or lungs and new (secondary) cancers like lymphoma, especially in patients who smoke now or smoked in the past. The most common side effects of Jakafi for certain types of myelofibrosis and PV include: low platelet or red blood cell counts, bruising, dizziness, headache, and diarrhea. Call your doctor for medical advice about side effects. To learn more about these and other risks, please read the Important Safety Information at https://www.jakafi.com/. Please see the Full Prescribing Information at https://www.jakafi.com/pi/pi, which includes a more complete discussion of the risks associated with Jakafi. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also report side effects to Incyte Medical Information at 1-855-463-3463. Sponsored by Incyte Corporation. Jakafi is a registered trademark of Incyte. © 2020, Incyte Corporation. MAT-JAK-03740 01/22